TNF and neoplasm: In addition, a study found that immune microenvironment can act as a source of resistance to MAPK pathway-targeted therapy, which is reinforced during combinational treatment; on the other hand, the increased TNF-α and tumor-associated macrophages by MAPK blockade may involve in developing immunosuppressive tumor microenvironment80.